Laboratoire Eurofins Dermscan Pharmascan
Villeurbanne, 69100, France
NCT Number: NCT05193799
This is a monocentric, open and randomized study. The purpose is to evaluate the cutaneous tolerance of three medical masks (class I medical device) after 3 consecutive days of use on a population with normal or sensitive skin.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Villeurbanne, 69100, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In terms of population
In terms of lifestyle
During 3 consecutive days
Time frame: Days 3
Evaluation of the percentage of subjects presenting no relevant clinical or functional signs of cutaneous intolerance after 3 days of use of the three medical devices
Time frame: 3 days
Analysis of the subject's answer to a subjective evaluation questionnaire
Time frame: 3 days
Collection of cutaneous and systemic Adverse Event
Groupe Kolmi Hopen
Industry
Monocentric, Open Study for the Evaluation of the Tolerance of Three Class I Medical Devices Under Dermatological Control.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06479330
Gastrointestinal Tolerance, Healthy Population
Toronto, Ontario, Canada
View Trial DetailsNCT07372482
Gastrointestinal Tolerance, Healthy Population
Toronto, Ontario, Canada
View Trial DetailsNCT06988384
Healthy Population
River Falls, Wisconsin, United States
View Trial DetailsNCT05999916
Alzheimer Disease, Brain Diseases
Basel, Canton of Basel-City, Switzerland
View Trial Details